Paper41007615
Enhanced M2 Polarization of Retinal Microglia in Streptozotocin-Induced Diabetic Mice upon Autoimmune Stimulation.
Nishio Y and 5 others. Biomedicines, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Enhanced M2 Polarization of Retinal Microglia in Streptozotocin-Induced Diabetic Mice upon Autoimmune Stimulation. Papers, record 41007615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007615
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced M2 Polarization of Retinal Microglia in Streptozotocin-Induced Diabetic Mice upon Autoimmune Stimulation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 23K09036 | Grant-in-Aid for Scientific Research | PubMed | ||
| 21H05044 | Grant-in-Aid for Scientific Research | PubMed | ||
| JP23gm1110009 | Japan Agency for Medical Research and Development | PubMed | ||
| JP23zf0127003 | Japan Agency for Medical Research and Development | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21450922 | Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21450922 | PubMed |
| 2 | 38564108 | Microglia in retinal angiogenesis and diabetic retinopathy. | Angiogenesis | 2024 | https://conductscience.org/library/papers/38564108 | PubMed |
| 3 | 39307461 | Shh regulates M2 microglial polarization and fibrotic scar formation after ischemic stroke. | Neurochem Int | 2024 | https://conductscience.org/library/papers/39307461 | PubMed |
| 4 | 31023885 | Retinal microglia initiate neuroinflammation in ocular autoimmunity. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31023885 | PubMed |
| 5 | 26292978 | Parainflammation, chronic inflammation, and age-related macular degeneration. | J Leukoc Biol | 2015 | https://conductscience.org/library/papers/26292978 | PubMed |
| 6 | 36866156 | Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. | EPMA J | 2023 | https://conductscience.org/library/papers/36866156 | PubMed |
| 7 | 37842315 | Macrophage/microglia polarization for the treatment of diabetic retinopathy. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37842315 | PubMed |
| 8 | 37219511 | Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/37219511 | PubMed |
| 9 | 29996768 | Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. | BMC Immunol | 2018 | https://conductscience.org/library/papers/29996768 | PubMed |
| 10 | 31481754 | CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization. | Cell Mol Immunol | 2020 | https://conductscience.org/library/papers/31481754 | PubMed |
| 11 | 24574437 | Evaluation of mouse experimental autoimmune uveoretinitis by spectral domain optical coherence tomography. | Br J Ophthalmol | 2014 | https://conductscience.org/library/papers/24574437 | PubMed |
| 12 | 24090198 | Targeting CCL5 in inflammation. | Expert Opin Ther Targets | 2013 | https://conductscience.org/library/papers/24090198 | PubMed |
| 13 | 23638076 | Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes. | PLoS One | 2013 | https://conductscience.org/library/papers/23638076 | PubMed |
| 14 | 37572827 | Intermittent fasting: A promising dietary intervention for autoimmune diseases. | Autoimmun Rev | 2023 | https://conductscience.org/library/papers/37572827 | PubMed |
| 15 | 30660629 | Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. | J Control Release | 2019 | https://conductscience.org/library/papers/30660629 | PubMed |
| 16 | 30684443 | Chronic hyperglycemia regulates microglia polarization through ERK5. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/30684443 | PubMed |
| 17 | 38887289 | Autoimmune uveitis attenuated in diabetic mice through imbalance of Th1/Th17 differentiation via suppression of AP-1 signaling pathway in Th cells. | Front Immunol | 2024 | https://conductscience.org/library/papers/38887289 | PubMed |
| 18 | 25476242 | Retinal microglia: just bystander or target for therapy? | Prog Retin Eye Res | 2015 | https://conductscience.org/library/papers/25476242 | PubMed |
| 19 | 38093014 | Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes. | Nature | 2023 | https://conductscience.org/library/papers/38093014 | PubMed |
| 20 | 36254977 | Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36254977 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41007615
GET https://conductscience.org/api/papers/v1/41007615/references?page=2